Details for New Drug Application (NDA): 017371
✉ Email this page to a colleague
NDA 017371 describes PRONESTYL, which is a drug marketed by Apothecon and is included in three NDAs. Additional details are available on the PRONESTYL profile page.
The generic ingredient in PRONESTYL is procainamide hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
The generic ingredient in PRONESTYL is procainamide hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
Summary for 017371
| Tradename: | PRONESTYL |
| Applicant: | Apothecon |
| Ingredient: | procainamide hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017371
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 375MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
